Status:
COMPLETED
Long-term Follow-up of Cognitive and Functional Evolutions of Persons With Isolated Cognitive Complaints or Mild Cognitive Deficits
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Alzheimer Disease
Eligibility:
All Genders
18+ years
Brief Summary
Dementia is a clinical syndrome that is the result of distinct underlying pathologies including Alzheimer's disease (AD). Despite more than two decades of research on prevention and treatment of demen...
Eligibility Criteria
Inclusion
- Participants aged over 18 year-old
- Being included in Memento cohort
- Affiliated person or beneficiary of a social security scheme.
- Participants capable of expressing non objection
- Non objection expressed by the tutor for participants under tutorship
- Non objection expressed by the participant assisted by their guardian for participants under guardianship
- Non objection expressed by the trusted person (in accordance with art. L1111-6 of Code de la Santé Publique) for participants without the capacity to express non-objection and who are not under legal protection measure
Exclusion
- Expressing opposition to participate in Memento-Plus
Key Trial Info
Start Date :
December 3 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 20 2024
Estimated Enrollment :
1028 Patients enrolled
Trial Details
Trial ID
NCT04111211
Start Date
December 3 2019
End Date
December 20 2024
Last Update
February 17 2025
Active Locations (26)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU d'Amiens
Amiens, France
2
AP-HP - CHU Avicenne
Bobigny, France
3
CHU de Bordeaux - Pellegrin
Bordeaux, France
4
CHU de Clermont-Ferrand
Clermont-Ferrand, France